Inventor · disambiguated record
John M. Maraganore
Also filed as: MARAGANORE JOHN · MARAGANORE JOHN M
22 granted patents·12 pending applications·434 citations·filing 1987–2025
96Inventor score
Files withALNYLAM PHARMACEUTICALS INC14BIOGEN INC11ROSSOMANDO ANTHONY3ZYMOGENETICS INC3ALNYLAM PHAMACEUTICALS INC1
Top patents by PatentIndex Score
34 records- 0191US5196404AInhibitors of thrombinBIOGEN INC·Filed 1990·Granted Mar 23, 1993·84 cites·37 claims
- 0290US9725718B2Compositions and methods for inhibition of expression of protein C (PROC) genesALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·3 cites·33 claims
- 0385US9068184B2Compositions and methods for inhibition of expression of protein C (PROC) genesTOUDJARSKA IVANKA·Filed 2012·Granted Jun 30, 2015·5 cites·24 claims
- 0485US5256559AMethods and compositions for inhibiting platelet aggregationBIOGEN INC·Filed 1991·Granted Oct 26, 1993·66 cites·16 claims
- 0584US10501740B2Compositions and methods for inhibiting expression of factor VALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Dec 10, 2019·2 cites·14 claims
- 0681US5433940AInhibitors of thrombinBIOGEN INC·Filed 1990·Granted Jul 18, 1995·36 cites·17 claims
- 0780US9441225B2Compositions and methods for inhibiting expression of factor VALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Sep 13, 2016·2 cites·18 claims
- 0879US5691311AMethods for coating invasive devices with inhibitors of thrombinBIOGEN INC·Filed 1995·Granted Nov 25, 1997·38 cites·15 claims
- 0978US11118181B2Compositions and methods for inhibition of expression of protein C (PROC) genesALNYLAM PHARMACEUTICALS INC·Filed 2019·Granted Sep 14, 2021·0 cites·20 claims
- 1078US8658782B2Compositions and methods for inhibiting expression of factor VVORNLOCHER HANS-PETER·Filed 2011·Granted Feb 25, 2014·2 cites·9 claims
- 1178US2021388360A1Compositions and methods for inhibition of expression of protein c (proc) genesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1277US5240913AInhibitors of thrombinBIOGEN INC·Filed 1991·Granted Aug 31, 1993·50 cites·30 claims
- 1377US2021189393A1Compositions and methods for inhibiting expression of factor vALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1476US12241064B2REVERSIR™ compoundsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Mar 4, 2025·0 cites·25 claims
- 1576US5242810ABifunctional inhibitors of thrombin and platelet activationBIOGEN INC·Filed 1990·Granted Sep 7, 1993·44 cites·12 claims
- 1673US2020056175A1Compositions and methods for inhibitiion of expression of protein c (proc) genesALNYLAM PHAMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1770US10273478B2Compositions and methods for inhibition of expression of protein C (PROC) genesALNYLAM PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·0 cites·28 claims
- 1870US2020231968A1Compositions and methods for inhibiting expression of factor vALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1969US2025257351A1Reversir tm compoundsALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2067US5182260ADna sequences encoding snake venom inhibitors of platelet activation processes for producing those inhibitors and compositions using themBIOGEN INC·Filed 1989·Granted Jan 26, 1993·18 cites·9 claims
- 2166US5446131AThrombin receptor antagonistsBIOGEN INC·Filed 1994·Granted Aug 29, 1995·18 cites·14 claims
- 2266US5196403AMethod of inhibiting platelet activationBIOGEN INC·Filed 1990·Granted Mar 23, 1993·26 cites·3 claims
- 2363US2010069461A1Compositions and methods for inhibiting expression of factor v leiden mutant geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2462US5425936AInhibitors of thrombinBIOGEN INC·Filed 1992·Granted Jun 20, 1995·17 cites·8 claims
- 2562US2017121709A1Compositions and Methods for Inhibiting Expression of Factor VALNYLAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2657US5514409AMethods for coating invasive devices with inhibitors of thrombinBIOGEN INC·Filed 1995·Granted May 7, 1996·9 cites·11 claims
- 2757US2017369872A1Reversir tm compoundsALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2846US2014363469A1Viral attenuation and vaccine productionALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2944US2013164329A1Cell-based methods and reagentsROSSOMANDO ANTHONY·Filed 2011·Application pending·0 cites
- 3042US4985541ANovel cytotoxic proteinZYMOGENETICS INC·Filed 1987·Granted Jan 15, 1991·8 cites·6 claims
- 3139US5149528ACytotoxic protein from Trichosanthes kirilowiiZYMOGENETICS INC·Filed 1989·Granted Sep 22, 1992·6 cites·19 claims
- 3237US2014099666A1Compositions and methods for enhancing production of a biological productROSSOMANDO ANTHONY·Filed 2010·Application pending·0 cites
- 3336US2014154783A1BioprocessingROSSOMANDO ANTHONY·Filed 2010·Application pending·0 cites
- 3430US5545615AA method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin IIIZYMOGENETICS INC·Filed 1994·Granted Aug 13, 1996·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →